Close Menu

NEW YORK (GenomeWeb) – Precision Therapeutics announced this week that it has completed its merger with Helomics, which has become Precision's wholly owned subsidiary. The merger provides Precision with full access to Helomics' suite of artificial intelligence, precision medicine, and integrated CRO capabilities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.